The combination of NBUVB, co2 fractional laser treatment of vitiligo
Phase 2
- Conditions
- VITILIGO.VITILIGO
- Registration Number
- IRCT2016031627072N1
- Lead Sponsor
- Vice chancellor for research, Shahid Beheshti University Skin Research Center of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Patients who entered the study were personal satisfaction.
2. under the age of 60 years and more than 18 years.
3 patients (based on the detection dermatologist) with vitiligo .
Exclusion criteria:
1. a history of allergy to the sun or UV radiation .
2. person or family history of skin cancer.
3. pregnancy and lactation.
4. ANA test is positive.
5. Fitzpatrick skin type 1.
6. Enable infection or history of skin infection with HSV.
7. Hypertrophic scars or keloids .
8. Heart failure.
9.Patients whit or a history of atypical nevus and melanoma.
10. Patients whit local or systemic treatment during the last three months .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of co2 Fractional laser and NBUVB of pigmentation of vitiligo lesions. Timepoint: Monthly until the end of the fourth month and at the end of the sixth month. Method of measurement: Disease severity index based on VASI.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Disease severity index based on VASI. Method of measurement: Ask the patient.